http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009541287-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1751 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 |
| filingDate | 2007-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2009541287-A |
| titleOfInvention | Use of cathelicidin antibacterial protein (hCAP18) as anticancer agent |
| abstract | The present invention provides a polypeptide comprising the amino acid sequence of SEQ ID NO: 1 (corresponding to the N-terminal 25 amino acid fragment of human antibacterial protein LL-37) or a biologically active fragment, variant thereof, in the preparation of a medicament for treating cancer Use of the fusion or derivative is provided. In particular, the present invention provides the use of such polypeptides or fragments, variants, fusions or derivatives thereof to inhibit the growth and / or metastasis of cancer cells such as breast cancer cells. The invention further includes a method of treating cancer in a patient. |
| priorityDate | 2006-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 210.